209 related articles for article (PubMed ID: 31634297)
1. Cerebrospinal Fluid Pleocytosis and Elevated C-X-C Motif Chemokine Ligand 13 Value Predict Lyme Borreliosis in Children With Facial Palsy.
Pöyhönen H; Lähdesmäki T; Hytönen J; Peltola V
Pediatr Infect Dis J; 2019 Dec; 38(12):1195-1198. PubMed ID: 31634297
[TBL] [Abstract][Full Text] [Related]
2. Borrelia burgdorferi sensu lato infection in patients with peripheral facial palsy.
Rojko T; Bogovič P; Lotrič-Furlan S; Ogrinc K; Cerar-Kišek T; Glinšek Biškup U; Petrovec M; Ružić-Sabljić E; Kastrin A; Strle F
Ticks Tick Borne Dis; 2019 Feb; 10(2):398-406. PubMed ID: 30553778
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy).
Bremell D; Hagberg L
BMC Infect Dis; 2011 Aug; 11():215. PubMed ID: 21831262
[TBL] [Abstract][Full Text] [Related]
4. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study.
Lindström J; Bremell D; Grahn A; Blennow K; Zetterberg H; Studahl M
Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115095. PubMed ID: 32610209
[TBL] [Abstract][Full Text] [Related]
7. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
8. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic difficulties in neuroborreliosis in children].
Talarek E; Duszczyk E; Zarnowska H
Przegl Epidemiol; 2007; 61(1):73-8. PubMed ID: 17702442
[TBL] [Abstract][Full Text] [Related]
10. Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis.
Cohn KA; Thompson AD; Shah SS; Hines EM; Lyons TW; Welsh EJ; Nigrovic LE
Pediatrics; 2012 Jan; 129(1):e46-53. PubMed ID: 22184651
[TBL] [Abstract][Full Text] [Related]
11. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
12. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
Rupprecht TA; Lechner C; Tumani H; Fingerle V
Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168
[TBL] [Abstract][Full Text] [Related]
13. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
Skogman BH; Lager M; Henningsson AJ; Tjernberg I
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
[TBL] [Abstract][Full Text] [Related]
14. Acute facial nerve palsy in children: how often is it lyme borreliosis?
Tveitnes D; Øymar K; Natås O
Scand J Infect Dis; 2007; 39(5):425-31. PubMed ID: 17464865
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy.
Belman AL; Reynolds L; Preston T; Postels D; Grimson R; Coyle PK
Arch Pediatr Adolesc Med; 1997 Dec; 151(12):1224-8. PubMed ID: 9412598
[TBL] [Abstract][Full Text] [Related]
17. CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.
Borde JP; Meier S; Fingerle V; Klier C; Hübner J; Kern WV
BMC Infect Dis; 2012 Dec; 12():344. PubMed ID: 23228054
[TBL] [Abstract][Full Text] [Related]
18. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
[TBL] [Abstract][Full Text] [Related]
19. The chemokine CXCL13 in acute neuroborreliosis.
Senel M; Rupprecht TA; Tumani H; Pfister HW; Ludolph AC; Brettschneider J
J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):929-33. PubMed ID: 19965843
[TBL] [Abstract][Full Text] [Related]
20. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum.
Zomer TP; Bruinsma R; van Samkar A; Vermeeren YM; Wieberdink RG; van Kooten B; van Bemmel T
Eur J Neurol; 2023 Mar; 30(3):741-744. PubMed ID: 36371644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
